Cargando…

Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis

The objective of this study was to assess deep vein thrombosis and pulmonary embolism (DVT/PE) recurrence rates and resource utilization among patients with an initial DVT or PE event across multiple payer perspectives. Retrospective analyses were performed using a software tool that analyzes health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Kathleen, Patel, Aarti A., Munsell, Michael, Bookhart, Brahim K., Mody, Samir H., Schein, Jeff R., Menzin, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379443/ https://www.ncbi.nlm.nih.gov/pubmed/25079971 http://dx.doi.org/10.1007/s11239-014-1108-z

Ejemplares similares

Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis
por: Lang, Kathleen, et al.
Publicado: (2014)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

EE238 Healthcare Costs of COVID-19 Versus Flu and Pneumonia - a Payer Perspective
por: Richards, F, et al.
Publicado: (2022)

One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events
por: Chen, Shih-Yin, et al.
Publicado: (2013)

Healthcare resource use and cost burden of urinary incontinence to United States payers
por: Datar, Manasi, et al.
Publicado: (2022)

EE422 Healthcare Costs Associated with Severe VS Moderate and Mild COVID-19 - a US Payer Perspective
por: Holy, C, et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Diabetes
por: Weir, Matthew R., et al.
Publicado: (2021)

Impact of Atrial Fibrillation on Stroke‐Related Healthcare Costs
por: Sussman, Matthew, et al.
Publicado: (2013)

Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
por: Kim, Samuel H, et al.
Publicado: (2018)

Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Tonsillectomy complicated by jugular vein thrombosis and pulmonary embolism
por: Flukes, Stephanie
Publicado: (2018)

Diffuse arterial embolization secondary to pulmonary vein thrombosis
por: Plowman, Keegan, et al.
Publicado: (2022)

MSR37 Identifying Clinical Subtypes of Long COVID: An Unsupervised Machine Learning Approach
por: Munsell, M., et al.
Publicado: (2023)

P9 Characteristics of Patients Diagnosed with Long COVID: Early Findings from Real-World Data
por: Munsell, M., et al.
Publicado: (2023)

Iron Deficiency Anemia as a Rare Risk Factor for Recurrent Pulmonary Embolism and Deep Vein Thrombosis
por: Ezeh, Ebubechukwu, et al.
Publicado: (2021)

Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database
por: Coleman, Craig I, et al.
Publicado: (2015)

Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
por: Laliberté, François, et al.
Publicado: (2013)

Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism
por: Streiff, Michael B., et al.
Publicado: (2016)

Deep Vein Thrombosis and Pulmonary Embolism in the Setting of Mycoplasma Infection
por: Saleem, Sandal, et al.
Publicado: (2020)

Anastrozole: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Tozinameran: Deep vein thrombosis and pulmonary embolism: case report
Publicado: (2021)

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
por: Menzin, Joseph, et al.
Publicado: (2014)

ML4 Application of Machine Learning Models to Evaluate COVID-19 Related ICU Utilization in a US Population
por: Icten, Z., et al.
Publicado: (2020)

Recurrent Deep Vein Thrombosis due to Thrombophilia
por: Rahman, Afzalur, et al.
Publicado: (2012)

The Predictive Factors of Recurrent Deep Vein Thrombosis
por: Farzamnia, Hamid, et al.
Publicado: (2011)

Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data
por: Lang, Kathleen, et al.
Publicado: (2014)

Deep vein thrombosis and pulmonary embolism – Prevention, management, and anaesthetic considerations
por: Narani, Krishan Kumar
Publicado: (2010)

Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism
por: Ogbonna, Kelechi C, et al.
Publicado: (2015)

Pulmonary embolism and deep vein thrombosis related to oral contraceptive use
por: Kim, Ji-Yeong, et al.
Publicado: (2013)

Pulmonary Embolism and Coexisting Deep Vein Thrombosis: A Detrimental Association?
por: Cordeanu, Elena-Mihaela, et al.
Publicado: (2019)

Silent Pulmonary Embolism in Deep Vein Thrombosis: Relationship and Risk Factors
por: Shi, Yadong, et al.
Publicado: (2022)

Concomitant Deep Vein Thrombosis in Cancer Patients with Unsuspected Pulmonary Embolism
por: Qdaisat, Aiham, et al.
Publicado: (2022)

Septic Pulmonary Embolism With Deep Vein Thrombosis and Bilateral Pleural Effusion
por: Mayekar, Mrinmayee V, et al.
Publicado: (2022)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Paradoxical embolism following thromboaspiration of an arteriovenous fistula thrombosis: a case report
por: Bentaarit, Bouteina, et al.
Publicado: (2010)

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug
por: Munsell, Michael, et al.
Publicado: (2016)

Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs
por: Munsell, Michael, et al.
Publicado: (2017)

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population
por: Berger, Jeffrey S., et al.
Publicado: (2023)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q5no0cbshftqmmtnmiiaoucrg6